Akebia Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.

About AKBA

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. 

CEO
John P. Butler
CEOJohn P. Butler
Employees
194
Employees194
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
194
Employees194

AKBA Key Statistics

Market cap
281.23M
Market cap281.23M
Price-Earnings ratio
-8.77
Price-Earnings ratio-8.77
Dividend yield
Dividend yield
Average volume
11.33M
Average volume11.33M
High today
$1.03
High today$1.03
Low today
$0.9529
Low today$0.9529
Open price
$0.9616
Open price$0.9616
Volume
2.43M
Volume2.43M
52 Week high
$3.20
52 Week high$3.20
52 Week low
$0.814
52 Week low$0.814

Stock Snapshot

Akebia Therapeutics(AKBA) stock is priced at $1.01, giving the company a market capitalization of 281.23M. It carries a P/E multiple of -8.77.

On 2026-09-08, Akebia Therapeutics(AKBA) stock traded between a low of $0.95 and a high of $1.03. Shares are currently priced at $1.01, which is +6.0% above the low and -1.9% below the high.

The Akebia Therapeutics(AKBA)'s current trading volume is 2.43M, compared to an average daily volume of 11.33M.

In the last year, Akebia Therapeutics(AKBA) shares hit a 52-week high of $3.20 and a 52-week low of $0.81.

In the last year, Akebia Therapeutics(AKBA) shares hit a 52-week high of $3.20 and a 52-week low of $0.81.

AKBA News

TipRanks 4d
Akebia’s Vadadustat Trial Nears Data Readout, Raising Stakes in Dialysis Anemia Market - TipRanks

...

Akebia’s Vadadustat Trial Nears Data Readout, Raising Stakes in Dialysis Anemia Market - TipRanks

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own AKBA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.